Improved Potency of Hyperactive and Actin-Resistant Human DNase I Variants for Treatment of Cystic Fibrosis and Systemic Lupus Erythematosus

Journal of Biological Chemistry - United States
doi 10.1074/jbc.273.29.18374
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Common DNase I Polymorphism Associated With Autoantibody Production Among Systemic Lupus Erythematosus Patients

Human Molecular Genetics
MedicineGeneticsMolecular Biology
2004English

Type I Interferon and Systemic Lupus Erythematosus

Journal of Interferon and Cytokine Research
MedicineVirologyImmunologyCell Biology
2011English

Steroid Treatment of Systemic Lupus Erythematosus

Ensho
1982English

Integral Treatment of Systemic Lupus Erythematosus

2011English

Systemic Lupus Erythematosus: Genetic Variants in Xq28 Region

Reumatologia
RheumatologyAllergyImmunology
2019English

Treatment Satisfaction in Systemic Lupus Erythematosus

Journal of Clinical Rheumatology
MedicineRheumatology
2017English

Systemic Lupus Erythematosus

JAMA - Journal of the American Medical Association
Medicine
2011English

Pathogenesis of Human Systemic Lupus Erythematosus: Recent Advances

Trends in Molecular Medicine
Molecular MedicineMolecular Biology
2010English

Guanoxan and Systemic Lupus Erythematosus

BMJ
1967English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy